Plant-based biologics are biopharmaceutical therapeutic agents derived from plant cell cultures through recombinant DNA technology. They are designed to offer the same therapeutic benefits as biologics derived from animal cells. Plant-based biologics have higher stability, lower production costs, ease of scalability and lack issues of animal pathogens. Some key examples include monoclonal antibodies, vaccines, blood factors and others.
The Global Plant-Based Biologics Market is estimated to be valued at US$ 15.8 Bn in 2024 and is expected to exhibit a CAGR of 8.2% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the Plant-Based Biologics market are DSM Nutritional Products, Lycored, Lycored SARL, FutureCeuticals, Vidya Herbs, Allied Biotech Corporation, Avestia Pharma, Xi'an Green Source Co., Ltd., Beijing Gingko Group (BGG), Shaanxi Jiahe Phytochem Co., Ltd. The demand for plant-based biologics is growing rapidly due to advantages over conventional animal cell culture derived biologics such as lower risk of contamination, faster production as well as scalability and lower costs. Technological advancements such as plant transient expression technologies and molecular farming offer enhanced yields, improved functionality and lower production costs further driving the market growth.
Market Trends
One of the key trends in the Plant-Based Biologics Market Demand is the adoption of transient plant expression systems. Transient plant expression involves quickly producing biopharmaceutical proteins in plants without the need for developing transgenic plants. This allows rapid, low-cost production at large scales. Another major trend is the development of next-generation platforms that can produce complex proteins such as antibodies with mammalian-like glycosylation patterns, thus expanding applications.
Market Opportunities
One of the major opportunities for plant-based biologics lies in vaccines as plant systems can produce vaccines at a lower cost compared to conventional methods. Plant-made vaccines can help lower costs and increase access especially for developing countries. The other major opportunity is in monoclonal antibodies as transient expression systems can produce similar product quality at lower costs, attracting pharma companies to develop cost-effective biosimilars.
Impact of COVID-19 on Plant-Based Biologics Market
The COVID-19 pandemic has significantly impacted the plant-based biologics market in both negative and positive ways. On the negative side, nationwide lockdowns led to disruptions in production and supply chain activities globally. Transport restrictions affected the movement of goods and raw materials required for manufacturing plant-based biologics. Research and development activities also slowed down during the peak of the pandemic.
However, on the positive side, the pandemic raised widespread awareness about health and immunity. This drove increased demand for plant-based therapeutic products seen as natural and safer alternatives to conventional drugs. Companies shifted focus to develop plant-based biologics targeting viral infections, respiratory illnesses, and immune system support. Government approvals accelerated for plant-based therapeutics undergoing clinical trials for COVID-19. Overall, while facing short term headwinds, the plant-based biologics market is poised to grow significantly in the long run driven by the heightened health consciousness post pandemic. Innovation and strategic investments will be key for players to capitalize on the opportunities.
North America dominates the global Plant-Based Biologics Market Regional Analysis in terms of value. This is due to the rising consumer preference for natural alternatives, growing elderly population needing medical care, and increasing investment by players in the region for R&D. The U.S. accounts for the major share of the North American as well as global market.
The Asia Pacific region is expected to be the fastest growing market for plant-based biologics during the forecast period. This is attributed to factors such as rising health expenditure, growing elderly demographics, increasing investments by international players in the region and expanding middle class demanding quality healthcare.
get more insights on plant-based biologics market
Pick the language that you prefer-
About Author-
Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.
(LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )
